Fulgent Genetics (NASDAQ:FLGT) Upgraded by Zacks Investment Research to Buy

Fulgent Genetics} stock has undergone multiple analysts rating changes in the recent past.  Fulgent Genetics Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Fulgent Genetics (NASDAQ:FLGT) Upgraded by Zacks Investment Research to Buy

Analysts Estimate Report : What to Look Out for Fulgent Genetics (NASDAQ:FLGT)

Earnings results for Fulgent Genetics , Analyst Opinion on Fulgent Genetics , Earnings and Valuation of (NASDAQ:FLGT), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Analysts Estimate Report : What to Look Out for Fulgent Genetics (NASDAQ:FLGT)

Wall street estimates Earnings report Fulgent Genetics (NASDAQ:FLGT)

Earnings results for Fulgent Genetics , Analyst Opinion on Fulgent Genetics , Earnings and Valuation of (NASDAQ:FLGT), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Wall street estimates Earnings report Fulgent Genetics (NASDAQ:FLGT)

Analyst Valuation and EPS Growth Fulgent Genetics (NASDAQ:FLGT)

Earnings results for Fulgent Genetics , Analyst Opinion on Fulgent Genetics , Earnings and Valuation of (NASDAQ:FLGT), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Analyst Valuation and EPS Growth Fulgent Genetics (NASDAQ:FLGT)